Cargando…
ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
INTRODUCTION: There are few data regarding ZAC1 expression in clinically non-functioning pituitary adenomas (NFPA). Because somatotropinomas and NFPA behave differently with respect to tumor shrinkage during somatostatin analogs (SA) therapy, we sought to compare the ZAC1 and somatostatin receptor (...
Autores principales: | Vieria Neto, Leonardo, Wildemberg, Luiz Eduardo, Colli, Leandro Machado, Kasuki, Leandro, Marques, Nelma Veronica, Moraes, Aline Barbosa, Gasparetto, Emerson L., Takiya, Christina Maeda, Castro, Margaret, Gadelha, Mônica Roberto |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3788723/ https://www.ncbi.nlm.nih.gov/pubmed/24098585 http://dx.doi.org/10.1371/journal.pone.0077406 |
Ejemplares similares
-
Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieira Neto, Leonardo, et al.
Publicado: (2013) -
Regulation of Aryl Hydrocarbon Receptor Interacting Protein (AIP) Protein Expression by MiR-34a in Sporadic Somatotropinomas
por: Dénes, Judit, et al.
Publicado: (2015) -
Growth hormone-releasing hormone-secreting pulmonary neuroendocrine tumor associated with pituitary hyperplasia and somatotropinoma
por: Lamback, Elisa B., et al.
Publicado: (2021) -
Apoplexy in sporadic pituitary adenomas: a single referral center experience and AIP mutation analysis
por: Fialho, Christhiane, et al.
Publicado: (2021) -
The Future of Somatostatin Receptor Ligands in Acromegaly
por: Gadelha, Monica R, et al.
Publicado: (2021)